A Retrospective rEal-life daTa Study to Assess the exaceRbations and Lung functIon in Chronic Obstructive Pulmonary Disease ( COPD ) patiEnts receiVing Fluticasone/Salmeterol Comparing to Those Εscalating in Open-triple Fluticasone/Salmeterol, Long Acting Muscarinic Antagonist (LAMA) Combination

NCT03858348 · clinicaltrials.gov ↗
COMPLETED
Status
1000
Enrollment
INDUSTRY
Sponsor class

Conditions

Sponsor

Elpen Pharmaceutical Co. Inc.